secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cullinan Therapeutics, Inc. (CGEM)
CIK:        0001789972
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001193125-22-181528
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cullinan Oncology shareholders re-elect Gadicke and Rosenberg as directors, ratify KPMG
--------------------------------------------------------------------------------

- Ansbert Gadicke elected with 27,033,605 votes for, 10,667,725 withheld, 4,141,978 broker non-votes.
- Anthony Rosenberg elected with 27,229,454 votes for, 10,471,876 withheld, same broker non-votes.
- KPMG ratified as independent auditor for FY2022: 41,825,399 for, 12,030 against, 5,879 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789972/000119312522181528/0001193125-22-181528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789972/000119312522181528/d516441d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-181528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer